Searched for
CURE PHARMACEUTICAL
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...- In the 1930s, rubber factory workers drank alcohol and suddenly felt sick. It wasn't just a workplace illness, it led to the discovery of Antabuse, helping millions quit drinkingAn accidental discovery in a rubber factory in the 1930s revealed that workers exposed to tetraethylthiuram disulfide experienced severe re...
- Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibioticWockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial re...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Experimental pancreatic cancer drug appears to dramatically improve one year survival ratesA groundbreaking study published in Nature Medicine reveals that the experimental drug Elraglusib, when combined with standard chemotherapy...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Drugs at your door: Signs of a disruption taking shape in IndiaIndia Pharmacy Retail Quick Commerce: India's medicine delivery is seeing a change. Quick-commerce apps are making it easier to buy medicin...
- J&J sees AI halving the time to generate drug development leadsJohnson & Johnson is leveraging artificial intelligence to significantly speed up drug development. The company has halved the time needed ...
- Paracetamol to PAN-D: CDSCO finds over 50 sub-standard drugs. Check full list of medicinesThe Central Drugs Standard Control Organisation (CDSCO) has flagged over 50 drugs, including Paracetamol, as 'not of standard quality'. The...
- Indian Pharma Congress: Gene-cell therapy, preventive medicine future of health care, says expert"The focus will be on prevention rather than cure. In this, citizens are diagnosed technically to see what diseases they could be afflicted...
- Colorcon buys TA-backed pharma firm Ideal CuresTA Associates, which has invested in more than 500 companies around the globe, has a wide exposure in India with investments such as Indira...
- Patanjali’s Coronil not WHO certified or approved; no traditional medicine certified by WHO for Covid curePatanjali Ayurveda managing director Acharya Balkrishna also tweeted that the GMP compliant Certificate of Pharmaceutical Product (CPP) to ...
- Bayer aims to help CureVac with COVID-19 vaccine output, says CEOThough inoculation campaigns have started around the world using various COVID-19 vaccines, many countries say their ability to get shots i...
- COVID-19 vaccine contender CureVac links up with BayerCureVac, based in the German city of Tuebingen, said last month that it expects first results by the end of March from its phase 3 clinical...
- Study shows Favipiravir provides multiple benefits in COVID-19 treatment: GlenmarkThe Phase 3 study with Favipiravir, sold under the brand name FabiFlu, by the company was conducted in 150 patients, it added. Favipiravir ...
- Germany tries to stop US from luring away firm seeking coronavirus vaccineOn its website, CureVac said CEO Daniel Menichella early this month met Trump, Vice President Mike Pence, members of the White House Corona...
- Johnson & Johnson arm halts R&D on Hepatitis C drugInstead, the company will focus on a cure for chronic hepatitis B, an inflammation of the liver caused by a different virus.
- Torrent Pharmaceuticals Shelcal 500 found substandard, Co claims it was counterfeitedThe entire batch was counterfeited by a third party which didn’t have the licence to manufacture this product, claimed the company in respo...
- National Pharma Pricing Policy may hurt industry in long-runPharma analysts in India and abroad believe that cost-based pricing in National Pharmaceutical Pricing Policy is not suitable to safeguard ...
- Ranbaxy, Herbs & Cures bank on soft loans for researchLeading drug makers are increasingly going for government funding for their new drug research.
Load More
